The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net income | 908,000 | 1,025,100 | 956,200 | 874,600 |
| Stock-based compensation | 24,000 | 20,700 | 21,200 | 27,100 |
| Amortization of purchased intangibles | 56,200 | 56,100 | 55,200 | 55,300 |
| Depreciation and amortization | 26,400 | 27,300 | -59,700 | 115,100 |
| Net realized and unrealized (gains) losses on investments | 400 | 0 | 2,600 | -8,100 |
| Deferred income taxes | -6,700 | -13,300 | -7,400 | -44,500 |
| Accounts receivable | -25,500 | -101,400 | 196,800 | -55,800 |
| Other current assets | -2,700 | 24,600 | 0 | -66,100 |
| Other assets | -51,600 | -13,300 | -16,500 | -37,300 |
| Accounts payable | -17,500 | -7,800 | 20,300 | -50,000 |
| Income taxes payable | -700 | -252,600 | 280,900 | 10,600 |
| Other current liabilities | -77,200 | 125,000 | -57,100 | -14,500 |
| Other liabilities | 1,600 | -6,400 | -2,800 | -38,400 |
| Other | 25,400 | 5,700 | -5,700 | -2,300 |
| Net cash provided by (used in) operating activities | 968,100 | 1,058,500 | 1,116,600 | 1,017,900 |
| Proceeds from maturities of available-for-sale marketable securities | 1,400 | 1,200 | 3,600 | 1,100 |
| Purchases of available-for-sale marketable securities | 1,100 | 800 | 3,000 | 200 |
| Purchases of property, net | 18,400 | 18,400 | 14,200 | 26,200 |
| Investments in privately-held equity investments | 1,000 | 0 | 2,400 | 0 |
| Proceeds from sales of investments | 0 | 0 | - | 0 |
| Investment in s&p dow jones indices llc | - | - | - | 0 |
| Net cash used in investing activities | -19,100 | -18,000 | -16,000 | -25,300 |
| Proceeds from debt, net of issuance costs | -1,700 | 0 | 742,300 | 0 |
| Repayment of other borrowings, including call premiums | - | - | - | 0 |
| Repayment of debt | 0 | 0 | 750,000 | - |
| Cash dividends | 455,300 | 455,300 | 2,567,400 | 418,800 |
| Repurchase of class a common stock, including costs | 0 | 8,200 | - | - |
| Change in performance bond and guaranty fund contributions | -6,883,200 | -21,463,400 | -21,799,100 | 17,967,400 |
| Employee taxes paid on restricted stock vesting | 22,200 | 600 | 8,200 | 3,500 |
| Other | -4,300 | -100 | -4,400 | -200 |
| Net cash provided by financing activities | 6,399,700 | 20,999,200 | 19,211,400 | -984,100 |
| Net change in cash, cash equivalents and restricted cash | 7,348,700 | 22,039,700 | 20,312,000 | 8,500 |
| Cash and cash equivalents at beginning of period | 144,145,800 | 122,106,100 | 101,794,100 | 101,785,600 |
| Cash and cash equivalents at end of period | 151,494,500 | 144,145,800 | 122,106,100 | 101,794,100 |
CME GROUP INC. (CME)
CME GROUP INC. (CME)